Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2025-12-25 @ 3:22 AM
NCT ID:
NCT01315405
Eligibility Criteria:
Inclusion Criteria:
* Patients with idiopathic Parkinson's disease according to UKPDSBB criteria - Men or women aged between 18 to 75 years
* Free from any visio-perceptive disorder (visual acuity and Vitec)
* Affiliated to National Health system
* Having given their informed consent
--Healthy controls
* Men or women aged between 18 to 75 years
* Free from any visio-perceptive disorder (visual acuity and Vitec)
* Affiliated to National Health system
* Having given their informed consent
Exclusion Criteria:
* With dementia or with significant dysexecutive disorder (MMS \<24, MATTIS\< 130)
* With fluctuations (\<5 Levodopa intakes / day)
* With severe depression (BDI \> 27)
* With psychiatric comorbidities (hallucinations, psychos) evaluated with l'Unified Parkinson's disease Rating Scale part I (UPDRS part I =0)
* With faces processing disorder (Benton \< 39)
* Pregnant
* Treatment with deep brain stimulation
* Under guardianship
* In excluding period for another study
--Healthy controls
* Suffering of neurological or psychiatric evolutive condition
* With severe depression (BDI \> 27)
* With faces processing disorder (Benton \< 39)
* Pregnant
* In excluding period for another study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01315405
Study Brief:
Protocol Section:
NCT01315405